We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
LEADOPTIK Inc., a Silicon Valley-based medical imaging company today announced that it has raised $5 million in an oversubscribed series seed funding, led by MetaVC Partners with participation from SOSV, Sony Innovation Fund, TSVC, ENEA, Arash Ferdowsi (co-founder
Massachusetts-based Sealonix has raised $20m in a Series A financing round for the development and commercialisation of haemostatic sealants using the company’s proprietary biomaterials. The early-stage funding round
Embecta, a US-based pure-play diabetes care company, has forged a partnership with Tidepool to develop automated insulin delivery (AID) system for people having type 2 diabetes (T2D). Tidepool
The Securities and Exchange Commission today announced that Amsterdam-based Koninklijke Philips N.V. will pay more than $62 million to resolve charges that it violated the Foreign Corrupt Practices
Mass General Brigham and Dana-Farber Cancer Institute are collaborating with BEEAH Group, an organization pioneering sustainability and quality of life solutions in the Middle East, to advise in
Cue Health said that it has submitted a De Novo application for its Cue RSV Molecular Test to the US Food and Drug Administration (FDA) to seek full
Lucence, a Singapore-based precision oncology company, has unveiled its multi-cancer early detection (MCED) blood test dubbed LucenceINSIGHT at its US headquarters. The unveiling event was graced by Singapore’s
Glooko, Inc., today announced the redesign of their award-winning mobile app for its connected care platform, that will provide a more streamlined experience for its mobile users. The
Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-based medical technology company focused on transforming ECGs/EKGs to save lives through the
Alcon said that results from a new non-interventional study showed that its Clareon monofocal intraocular lenses (IOLs) and TECNIS Eyhance monofocal IOLs offer a similar range of vision.